Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?

Social Science and Medicine

Volumn 69, Issue 11, 2009, Pages 1643-1650

  Granlund, David ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Doctors; Drugs; Fee for service; Moral hazard; Prescriptions; Salary; Sweden

Indexed keywords

GENERIC DRUG;

DRUG PRESCRIBING; HEALTH SERVICES; HEALTH WORKER; MORALITY; PHARMACEUTICAL INDUSTRY; WAGE;

ARTICLE; DRUG COST; DRUG INDUSTRY; EUROPE; FINANCIAL MANAGEMENT; HEALTH INSURANCE; HOSPITAL PHYSICIAN; HUMAN; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIVATE PRACTICE; PROBABILITY; SALARY; SWEDEN; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; COST CONTROL; DRUG COSTS; DRUG PRESCRIPTIONS; DRUGS, GENERIC; FEMALE; FINANCING, PERSONAL; HEALTH CARE REFORM; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PRIVATE SECTOR; SWEDEN;

EURASIA; EUROPE; NORTHERN EUROPE; SCANDINAVIA; SWEDEN; VASTERBOTTEN;

EID: 71549137742     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2009.09.016     Document Type: Article

References (20)

1. Blomqvist A. The doctor as double agent: information asymmetry, health insurance, and medical care. Journal of Health Economics 10 (1991) 411-432
2. Boyes W., Hoffman D., and Low S. An econometric analysis of the bank credit scoring problem. Journal of Econometrics 40 (1989) 3-14
3. Coscelli A. The importance of doctors' and patients' preferences in prescription drug markets. Journal of Industrial Economics 48 (2000) 349-369
4. Crown W.H., Berndt E.R., Baser O., Finkelstein S.N., Witt W.P., Maguire J., et al. Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?. Frontiers In Health Policy Research 7 (2004) 95-127
5. Dusheiko M., Gravelle H., Jacobs R., and Smith P. The effect of financial incentives on gatekeeping doctors: evidence from a natural experiment. Journal of Health Economics 25 (2006) 447-478
6. Gosden T., Pedersen L., and Torgerson D. How should we pay the doctors? A systematic review of salary payments and their effect on doctor behaviour. Quarterly Journal of Medicine 92 (1999) 47-55
7. Granlund D., Rudholm N., and Wikström M. Fixed budgets as a cost containment measure for pharmaceuticals. The European Journal of Health Economics 7 (2006) 37-45
8. Greene W.H. A statistical model for credit scoring. Working Paper EC-92-29 (1992), New York University
9. Greene W.H. Econometric analysis. 5th ed (2003), Prentice Hall, New York
10. Hellerstein J.K. The importance of the physician in the generic versus trade-name prescription decision. RAND Journal of Economics 29 (1998) 108-136
11. Leibowitz A., Manning W.G., and Newhouse J.P. The demand for prescription drugs as a function of cost-sharing. Social Science & Medicine 21 (1985) 1063-1069
12. Lundin D. Moral hazard in physician prescription behavior. Journal of Health Economics 19 (2000) 639-662
13. Manski C.F., and Lerman S.R. The estimation of choice probabilities from choice based samples. Econometrica 45 (1977) 1977-1988
14. Mossialos E., Walley T., and Rudisill C. Provider incentives and prescribing behaviour in Europe. Expert Review of Pharmacoeconomics Outcomes Research 5 (2005) 81-93
15. Mott D.A., and Cline R.R. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Medical Care 40 (2002) 662-674
16. Nassiri A., and Rochaix L. Revisiting physicians' financial incentives in Quebec: a panel system approach. Health Economics 15 (2006) 49-64
17. Pauly M.V. The economics of moral hazard: comment. The American Economic Review 58 (1968) 531-537
18. Ross S.A. The economic theory of agency: the principal's problem. The American Economic Review 63 (1973) 134-139
19. Rudholm N. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden. Scandinavian Journal of Public Health 33 (2005) 50-56
20. Shortell S.M. Physicians as double agents: maintaining trust in an era of multiple accountabilities. Journal of the American Medical Association 280 (1998) 1102-1108